To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
333 Current news of Evonikrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
The specialty chemicals company has already begun construction of a new polyamide 12 (PA 12) facility complex and is expanding its production of transparent polyamides at the Marl Chemical Park, and, in so doing, is concentrating its activities on high-performance materials for attractive growth ...
Evonik made a solid start to the new year. Sales in the first quarter rose 1 percent to €3.29 billion compared to the prior-year quarter. Adjusted EBITDA declined 3 percent to €539 million. “In a weakening global economy we were able to hold our ground in terms of sales and earnings,” said ...
Due to increasing global demand for high-performance polymers, Evonik is expanding its production of transparent polyamides of the TROGAMID® CX brand at the Marl Chemical Park (Germany). Production expansion is scheduled for completion in the first quarter of 2020. The project will double the ...
New materials allow thin and flexible energy storage devices
Evonik is unveiling TAeTTOOz®, a new material technology for printable batteries, at the LOPEC trade show. TAeTTOOz® has been developed on the basis of what are known as redox polymers by Creavis, the strategic innovation unit of Evonik. The new materials can be processed by conventional printing ...
Promised and delivered: adjusted EBITDA climbs to €2.6 billion
Evonik grew again strongly in 2018. Adjusted EBITDA increased 10 percent to €2.6 billion, compared with the previous year. All three chemical segments contributed to profit growth. The earnings forecast, that Evonik had raised after the first half of the year, was achieved despite external ...
Consistent strategy execution to focus on specialty chemicals
Evonik has signed an agreement to sell its Methacrylates business to Advent International for €3 billion. The selling price (enterprise value) is 8.5 times the business’ EBITDA. The transaction is subject to approval by the authorities in several countries and is expected to close in the third ...
Evonik More Than Doubles Venture Capital to Accelerate Innovation
Evonik has launched its second venture capital fund with a volume of €150 million, more than doubling the amount under management to €250 million. The new fund will help secure access to disruptive technologies and innovative business models as well as supporting Evonik’s digital transformation ...
Evonik has acquired Structured Polymers Inc., a US-based technology startup for 3D printing materials headquartered in Austin, Texas. A corresponding agreement and plan of merger was executed and the transaction has been closed recently. The acquisition will provide Evonik access to a new ...
Johann-Caspar Gammelin, currently Chairman of the Board of Management of Evonik Performance Materials GmbH, will take over as Chairman of the Board of Management of Evonik Nutrition and Care GmbH from Dr. Reiner Beste, effective April 1, 2019. On this date Dr. Beste, as new Regional President, ...
Company continues to focus on high-margin specialty chemicals businesses
Evonik has concluded the sale of its Jayhawk site in Galena (Kansas, USA), taking the next step on the road to a consistent focus on specialty chemicals. Funds advised by Permira, an international investment company, acquired the site at a price in the high double-digit million dollar range. The ...